BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18705415)

  • 1. Prolonged survival of a patient affected by pancreatic adenocarcinoma with massive lymphocyte and dendritic cell infiltration after interleukin-2 immunotherapy. Report of a case.
    Nobili C; Degrate L; Caprotti R; Franciosi C; Leone BE; Trezzi R; Romano F; Uggeri F; Uggeri F
    Tumori; 2008; 94(3):426-30. PubMed ID: 18705415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients.
    Degrate L; Nobili C; Franciosi C; Caprotti R; Brivio F; Romano F; Leone BE; Trezzi R; Uggeri F
    Langenbecks Arch Surg; 2009 Jan; 394(1):115-21. PubMed ID: 18670745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer.
    Morse MA; Nair SK; Boczkowski D; Tyler D; Hurwitz HI; Proia A; Clay TM; Schlom J; Gilboa E; Lyerly HK
    Int J Gastrointest Cancer; 2002; 32(1):1-6. PubMed ID: 12630764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative interleukin-2 immunotherapy in pancreatic cancer: preliminary results.
    Angelini C; Bovo G; Muselli P; Mussi C; Crippa S; Caprotti R; Uggeri F
    Hepatogastroenterology; 2006; 53(67):141-4. PubMed ID: 16506394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anatomy of the head of the pancreas and various limited resection procedures for intraductal papillary-mucinous tumors of the pancreas].
    Kimura W
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):460-70. PubMed ID: 12854493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
    Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
    Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for mucin-producing pancreatic tumor.
    Yasuda H; Takada T; Amano H; Yoshida M
    Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
    Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
    Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
    Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
    Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
    Spitz FR; Abbruzzese JL; Lee JE; Pisters PW; Lowy AM; Fenoglio CJ; Cleary KR; Janjan NA; Goswitz MS; Rich TA; Evans DB
    J Clin Oncol; 1997 Mar; 15(3):928-37. PubMed ID: 9060530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two Cases Pancreatic Carcinoma Detected Incidentally during Treatment of Acute Abdomen from Other Causes].
    Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1662-1664. PubMed ID: 28133091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.